S J Connor - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S J Connor

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Expert Opinion on Drug Safety|November 1, 2023

Ustekinumab as induction and maintenance therapy for ulcerative colitis - national extended follow-up and a review of the literatureJ D Chetwood, S Gupta, K Subramaniam, et al.

Internal Medicine Journal|March 4, 2015

Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.

Alimentary Pharmacology & Therapeutics|October 14, 2017

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseasesN Mitrev, N Vande Casteele, C H Seow, et al.

Alimentary Pharmacology & Therapeutics|December 21, 2016

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort studyJ D Doecke, F Hartnell, P Bampton, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Expert Opinion on Drug Safety|November 1, 2023

Ustekinumab as induction and maintenance therapy for ulcerative colitis - national extended follow-up and a review of the literatureJ D Chetwood, S Gupta, K Subramaniam, et al.

Internal Medicine Journal|March 4, 2015

Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.

Alimentary Pharmacology & Therapeutics|October 14, 2017

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseasesN Mitrev, N Vande Casteele, C H Seow, et al.

Alimentary Pharmacology & Therapeutics|December 21, 2016

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort studyJ D Doecke, F Hartnell, P Bampton, et al.

Pageof 4